Substitution of coagulation factor XIII partially restores scar healing after myocardial infarction in factor XIII knockout mice  by Nahrendorf, Matthias et al.
JACC March 19,2003 ABSTRACTS - Myocardial Ischemia and Infarction 395A 
POSTER SESSION 1194-104 Substitution of Coagulation Factor XIII Partially 
Restores Scar Healing After Myocardial Infarction in 
Factor XIII Knockout Mice 
Matthias Nahrendorf, Kai Hu, Karl-Heinz Hiller, Christiane Wailer, Stefan Gattenlbhner, 
Gerhard Dickneite, Axe1 Haase, Wolfgang R. Bauer, Georg Ertl, Medizinische Klinik, 
Wtirzburg, Germany 
Background. Clotting factor XIII (FXIII) has been shown to have a role in healing pro- 
cesses in &sues as skin, bone and cartilage. Because this role may be universal in the 
organism, we studied healing after coronary artery ligation in factor XIII knock out (FXIII 
KO) and wild type mice. 
Methods. Magnetic resonance imaging was performed 1 day, 7 and 42 days after myo- 
cardial infarction (Ml) in a 7 Tesla Biospec using an ECG-triggered cme-sequence: slice 
thickness 1 mm, echo-time 1.2 ms. resolution 0.23 mm. Cardiac volumes and index, 
ejection fraction, scar thickness and left ventricular mass were determined. To minimize 
bleeding from the thoracotomy wound, FXIII-free fibrin glue was applied. 5 groups of 6-12 
mice were studled: wild type MI, FXIII KO MI, FXIII KO sham operated, FXIII KO Ml with 
iv. substitution of FXIII (200 U/kg via tail vein for 5 days). 
Results. All FXIII KO mice died within 3 to 5 days after MI, whereas wild type mice, sham 
operated KO mice and KO mice with Ml and iv. substitution of FXllf survived the sub- 
acute period (7 days). Histology revealed rupture of the infarct area with little inflamatory 
response to lschemia in the knock out group. Substituted KO mice survived, but the inf- 
arct scar was thinner than in wild type 1 week after Ml (Wl 0.66+/-O.O3mm, KO plus iv. 
FXIII 0.37+/-0.06mm. p<O.O05). LV dilatation was more pronounced in KO than in wild 
type (increase of end-diastolic volume from day 1 to 42 after MI, wild type 33.2~1~5.2~1, 
KO 68.3+/-10.2pl. pcO.05). Left ventricular mass and cardiac index were not significantly 
different between wild type and KO 42 days after Ml. Ejection fraction of KO was not sig- 
nificantly lower in KO (wild type 51.7+/-5%, KO 43.8+/-6.9% p=ns). 
Conclusion. These data show that FXIII may have a major role I” healing processes post 
myocardial infarction. When compared to wild type, scar healing in substituted KO was 
not completly restored as indicated by a thinner scar. This may be explained by the fact 
that the largest part of FXIII in wild type is transported inside platelets which home in at 
sites of injury, whereas in substituted FXIII knock out mice FXIII was transported in the 
plasma. 
1194-105 Inhibition of Nuclear Factor Kappa 6 Activation by 
lntramyocardial Adenovirus-Mediated Gene Transfer 
Attenuates Ventricular Remodeling Following 
Myocardial Infarction 
Karola Trescher. Oliver Bernecker, Barbara Fellner, Severin Semsroth, Mariann 
Gydngybsi, Roman Gottardi, Rainer DeMartin, Ernst Wolner, Bruno Podesser, Ludwig 
Boltzmann Institute of Cardiosurgical Research, Vienna, Austria 
Background: One of the key factors in the inflammatory response following myocardial 
infarction is the transcription factor nuclear factor kappa B (NF-kB). We hypothesized 
that NF-kB- blockade in an animal model of acute ischemia reduces the inflammatory 
response and therefore improves myocardial function. 
Methods: NF-kB - blockade was achieved by an overexpression of Inhibitor kappa Ba 
(IkBa) usmo adenoviral (AV) - mediated oene transfer. Mvocardial infarcts (MI) were pro- _ ., 
duced in male Sprague-Dawley rats by ligation of the left descending coronary artery and 
followed bv AV-mediated intramvocardial dellverv of IkBa-oene (394r17.10. n=6) _ . _. 
respectively the delivery of a LacZ-reporter-gene (392+/-25.39; n=6 ). Sham-operated 
animals (385*17,6g, n=6) received neither ligation nor gene transfer. In viva cardiac 
function was assessed 7 weeks after Ml by transthoracic echocardiography(Vingmed 
Sound). In vitro cardiac function was evaluated by pump function curves on a red-cell- 
perfused isolated working heart. Only ammals with Ml involving more than 30% of the left 
ventricle were included. 
Results: There was no difference in myocardlal infarction (45%+/-0.09) and left-ventricu- 
lar-body-weight-rat10 (0.0033+/-0,0007 ver.sus 0,0032+/-0,0002) between the Infarct 
groups. However this value was significantly elevated compared to sham-rats (0,0025+/- 
O,OOO2; p<O,O5). Concerning in viva hemodynamics lkba treated hearts showed reduced 
systoltc and diastolic left ventricular dimensions compared to the LacZ Ml group (systolic 
0,52+/-0,084 cm versus 0,66+/-0,031 cm; diastolic 0.7+/-0,081 cm versus 0,82+/-0,073 
cm; p.zO.05) Consequently fractional shortening was preserved m lkba hearts compared 
to LacZ Ml hearts (0,26+/-0,037 versus 0,19+/-0,042; pcO,O5). In vitro hemodynamics 
showed a similar picture: both infarct groups showed a significant left-and-downward- 
shift compared to the sham-operated hearts, this shift was less pronounced in the Ikb 
group (pcO,O5) compared to the LacZ Ml group. Data are given as mean +/- SD. 
Conclusion: It can be concluded that the overexpression of IkBu leads to an improved 
cardiac function thereby attenuating post-infarct-remodeling. 
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1195-89 The Impact of Contemporary Therapy on the Accuracy 
of Risk Stratification Models in Acute Coronary 
Syndromes 
James E. Calvin, Jr., Nasseer Nasser, Ryan Altier, Lloyd W. Klein, Rush-Presbyterian-St. 
Luke’s Medical Center, Chicago, IL 
Background: It is unresolved whether aggressive medical therapy, including the early 
use of glycoprotein Ilb/llla platelet receptor antagonists (GP2b/3a PRA’s) or low molecu- 
lar weight heparin (LMWH). have altered the accuracy of risk stratification models vali- 
dated before their widespread use. To explore this question, a prospective cohort of 451 
acute coronary syndrome patients was studied between June 1999 and December 2001. 
This population was aggressively treated using guideline reminder systems such that 
60% of patients received low molecular weight heparin (an additional 18% received 
unfractionated heparin) and 25% received GP2b/3a PRA’s prior to intervention (43% of 
patients received GP2613a PRA’s overall). Complications wt?re defined as a composite of 
death, myocardial infarction after 24h, new heart failure, cardiac arrest, shock or urgent 
revascularization. Event rates were compared according to TIMI score and Rush clinical 
score (Class I < 2% risk vs. Class IV = 35% risk). 
Results: The overall event rate was 11% (n=45). Event rates for TIMI score were 1 point, 
13%; 2 points, 29%; 3, 31%; 4, 20%; 5, 20%; 6, 7%; 7, 0% (PNS) and for Rush score 
Class I, 17%: II, 13%: Ill, 8%; IV, 8% (PNS). Coronary intervention was similar across all 
risk categories for both models. While trends were noted for high LMWH use in lowest 
categories of both scores (TIMI score 1 point, 20% vs. 7 points, 68% (P=NS); and Rush 
score (Class I, 48% vs. Class Iv, 57%, P=NS ), GP2b/3a PRA’s were prescribed more 
frequently in pabents with ST abnormalities, (28% vs. 8%, P=.Ol6), and diabetes (36% 
vs. 19%. P=.OOl), patients with high Rush scores (IV, 32% vs I, 17%, P=.O4), and high 
TIMI scores (S/7, 38% “s O/l, 15%, P=.Ol9). 
Conclusions: In an era of aggressive medical therapy of acute coronary syndromes. the 
use of risk scores, especially in those patients identified as being in the highest category 
of risk, may overestimate actual event rates. In part, this finding is related to more fre- 
quent use of new antithrombotic agents in these higher risk categories, resulting in a 
decrease in actual complications. 
1195-90 Serial Changes in CK-MB Are Superior to Myoglobin for 
Rapid Identification of Myocardial Infarction 
Michael C. Kontos, F. Philip Anderson, Joseph P. Omato, James L. Tatum, Robelt L. 
Jesse, Virginia Commonwealth University/Medical College of Virginia, Richmond, VA 
Background: Early identification of patients (pts) with acute myocardial infarction (Ml) is 
necessary to i&late appropriate treatment. In pts presenting without ST-segment eleva- 
tion, diagnosis IS often dependent on the presence of elevated myocardial markers. 
Recent studies have indicated that serial changes in myoglobin (Myo) and CK-MB can 
improve sensitivity for early diagnosis. However, the optimal diagnostic marker strategy 
has not been defined. Methods Consecutive pts without ST elevation underwent serial 
assessment of Myo (0 and 3 hrs), CK and CK-MB (0,3,6. and 8 hours) after admission. 
Ml was diagnosed if CK-MBz 8 ng/mL with a relative index 24. Different strategies using 
serial changes in CK-MB and Myo were examined (doubling of CK-MB or doubling Myo 
from the 0 to the 3 hour sample).ResultK Of the 2093 consecutive pts, 186 (8.9%) had 
Ml. Doubling of CK-MB or doubling of Myo from the 0 to 3 hour sample significantly 
improved sensitivity when compared to the 0 or 3 hour CK-MB alone (Table). However, 
using Myo significantly reduced specificity, with almost a doubling in the number of pts 
who did not have Ml. Conclusions Doubling of CK-MB over 3 hours significantly 
increased sensitivity. Compared to serial changes in Myo, sensitivity was similar but 
specificity was significantly higher. Myo on the Initial sample significantly improved sensi- 
tivity, but the number of false positives must be taken into account, as this markedly 
decreased specificity, and could potentially lead to inappropriate therapy. 
Sens Spec False Positives (%) 
CK-MB 0 49 98 45 (2.2) 
CK-MB + Myo 0 69’ 84’ 296 (14) 
CK-MB 0 + CK-MB 3 81 97 52 (2.5) 
CK-MB 0 + CK-MB 3 + CK-MB doubling 94 * 95 * 97 (4.6) 
CK-MB 0 + CK-MB 3 + Myo doubling 90 * 91 ‘# 177 (8.4) 
*=p<O.Ol compared to MB 0 or MB 0 + MB 3; #=pcO.Ol compared to MB 
O+MB3+MB doubling 
